Presenting At The Upcoming Scientific Conventions

KBP will attend two scientific conferences this coming Spring to present our recent findings.

The first one is the NKF Spring Clinical Meetings on April 27th in Boston. A KBP team will have a poster presentation titled “Pharmacological Profile of KBP-5074, A Novel Non-Steroidal, Highly Selective, Mineralocorticoid Receptor Antagonist (MRA) For The Treatment of Cardiorenal Diseases”.  KBP-5074 is currently in a Phase IIa study in CKD patients.

 

Then on June 16th, a KBP team will present 3 posters at the ASM Microbe 2016 conference. These posters focus on another lead compound, KBP-7072, a new generation of tetracycline with broad antibacterial efficacies. These posters will cover:

  • Antibacterial Activity of KBP-7072 Against Clinical Isolates of Drug-Resistant Bacteria
  • Effect of KBP-7072 on Bacterial Activity and Survival in a Klebseilla pneumoniae-induced Murine Pneumonia Model
  • Effect of KBP-7072 on Bacterial Activity and Survival in a S. pneumoniae-induced Murine Pneumonia Model

Please look us up. We hope to see you there.